The global bioelectric medicine market size reached US$ 22.3 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 35.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2023-2032.
Bioelectric medicine or electroceuticals encompasses medical-related devices that utilize electrical impulses and signaling in the nervous system. It combines molecular medicine, neuroscience, and bioengineering to develop nerve-stimulating technologies for biological processes during the treatment of diseases. It consists of cochlear, retinal implants, relief, cardiac pacemakers, spinal cord stimulators, and implantable defibrillators. Bioelectric medicine includes tiny electronic implants that can diagnose and treat various chronic diseases, such as rheumatoid arthritis, inflammatory bowel disease, cancer, obesity, diabetes, asthma, paralysis, and cardiovascular diseases (CVDs). It can treat a wide range of conditions and disorders using both non-invasive and invasive approaches.
Apart from this, manufacturers are launching smart products that help in the early detection and diagnosis of cardiac arrhythmias and cater unmet needs of the consumers, which, in turn, is providing an impetus to the market growth. Moreover, increasing approvals for advanced bioelectric medicine and a rise in investment and funding of new therapies and electroceuticals are positively influencing the market growth. Besides this, extensive research and development (R&D) activities, significant growth in the healthcare infrastructure, increasing expenditure capacities of consumers, and the presence of advanced medical devices for treatment purposes are supporting the market growth.
2. What is the expected growth rate of the global bioelectric medicine market during 2024-2032?
3. What are the key factors driving the global bioelectric medicine market?
4. What has been the impact of COVID-19 on the global bioelectric medicine market?
5. What is the breakup of the global bioelectric medicine market based on the type?
6. What is the breakup of the global bioelectric medicine market based on the product?
7. What is the breakup of the global bioelectric medicine market based on the application?
8. What is the breakup of the global bioelectric medicine market based on the end use?
9. What are the key regions in the global bioelectric medicine market?
10. Who are the key players/companies in the global bioelectric medicine market?
Bioelectric medicine or electroceuticals encompasses medical-related devices that utilize electrical impulses and signaling in the nervous system. It combines molecular medicine, neuroscience, and bioengineering to develop nerve-stimulating technologies for biological processes during the treatment of diseases. It consists of cochlear, retinal implants, relief, cardiac pacemakers, spinal cord stimulators, and implantable defibrillators. Bioelectric medicine includes tiny electronic implants that can diagnose and treat various chronic diseases, such as rheumatoid arthritis, inflammatory bowel disease, cancer, obesity, diabetes, asthma, paralysis, and cardiovascular diseases (CVDs). It can treat a wide range of conditions and disorders using both non-invasive and invasive approaches.
Bioelectric Medicine Market Trends:
The growing geriatric population and the increasing incidences of cardiovascular and neurological disorders across the globe are creating a positive outlook for the market. Bioelectric medicine uses the deep brain, vagus sacral, and transcutaneous electric nerve stimulator to treat these conditions. In line with this, the escalating prevalence of arrhythmia that involves the use of implantable cardioverter-defibrillators and cardiac pacemakers to treat the ailment is acting as another growth-inducing factor. Additionally, the increasing demand for deep brain stimulators owing to the rising instances of Parkinson's disease and lifestyle-induced disorders, such as depression and obesity, is favoring the market growth.Apart from this, manufacturers are launching smart products that help in the early detection and diagnosis of cardiac arrhythmias and cater unmet needs of the consumers, which, in turn, is providing an impetus to the market growth. Moreover, increasing approvals for advanced bioelectric medicine and a rise in investment and funding of new therapies and electroceuticals are positively influencing the market growth. Besides this, extensive research and development (R&D) activities, significant growth in the healthcare infrastructure, increasing expenditure capacities of consumers, and the presence of advanced medical devices for treatment purposes are supporting the market growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global bioelectric medicine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product, application and end use.Breakup by Type:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
Breakup by Product:
- Implantable Cardioverter Defibrillators
- Cardiac Pacemakers
- Cochlear Implants
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Transcutaneous Electrical Nerve Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Others
Breakup by Application:
- Arrhythmia
- Pain Management
- Sensorineural Hearing Loss
- Parkinson’s Disease
- Tremor
- Depression
- Treatment-Resistant Depression
- Epilepsy
- Urinary and Fecal Incontinence
- Others
Breakup by End Use:
- Hospitals
- Research Institutes
- Individual Users
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Biotronik SE & Co KG, Boston Scientific Corporation, Cochlear Limited, electroCore Inc., LivaNova PLC, MED-EL Medical Electronics, Medtronic plc and Sonova Holding AG.Key Questions Answered in This Report
1. How big is the global bioelectric medicine market?2. What is the expected growth rate of the global bioelectric medicine market during 2024-2032?
3. What are the key factors driving the global bioelectric medicine market?
4. What has been the impact of COVID-19 on the global bioelectric medicine market?
5. What is the breakup of the global bioelectric medicine market based on the type?
6. What is the breakup of the global bioelectric medicine market based on the product?
7. What is the breakup of the global bioelectric medicine market based on the application?
8. What is the breakup of the global bioelectric medicine market based on the end use?
9. What are the key regions in the global bioelectric medicine market?
10. Who are the key players/companies in the global bioelectric medicine market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Bioelectric Medicine Market
6 Market Breakup by Type
7 Market Breakup by Product
8 Market Breakup by Application
9 Market Breakup by End Use
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Biotronik SE & Co KG
- Boston Scientific Corporation
- Cochlear Limited
- electroCore Inc.
- LivaNova PLC
- MED-EL Medical Electronics
- Medtronic plc
- Sonova Holding AG
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 146 |
Published | August 2024 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 22.3 Billion |
Forecasted Market Value ( USD | $ 35.5 Billion |
Compound Annual Growth Rate | 5.3% |
Regions Covered | Global |
No. of Companies Mentioned | 9 |